Trial Profile
Impact of light dose on the efficacy of Photodynamic therapy with 5-aminolaevulinic acid (5-ALA) and a 635 +- 9nm emitting LED-lamp for the treatment of actinic keratoses - a randomized, observer-blinded, intraindividual trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2023
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 11 Mar 2023 Status changed from recruiting to completed.
- 07 Mar 2016 New trial record